Parkworth Wealth Management’s Astera Labs ALAB Stock Holding History

Parkworth Wealth Management’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$452	Buy	+5	New	+$395	﹤0.01%	670

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Parkworth Wealth Management's ALAB Position: Q2 2025 in Review

Parkworth Wealth Management opened a new position in Astera Labs (ALAB) in Q2 2025: 5 shares worth $452. The stake represents ﹤0.01% of the portfolio and ranks #670 among its holdings.

513 funds tracked by Wall St. Rank hold ALAB as of Q2 2025.

Parkworth Wealth Management held 5 shares of Astera Labs worth $452 as of Q2 2025.
Astera Labs was a new Parkworth Wealth Management position in Q2 2025.
Astera Labs made up ﹤0.01% of Parkworth Wealth Management's portfolio in Q2 2025, its #670 holding.
513 funds tracked by Wall St. Rank held Astera Labs as of Q2 2025.

Based on Parkworth Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.